Epidemiology of sickle cell disease in Saudi Arabia

Annals of Saudi Medicine

Volumn 31, Issue 3, 2011, Pages 289-293

  Jastaniah, Wasil ^a,b  

^a UMM AL QURA UNIVERSITY   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S;

CLINICAL FEATURE; DISEASE SEVERITY; GENETIC DISORDER; GEOGRAPHIC DISTRIBUTION; HUMAN; MORBIDITY; MORTALITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAUDI ARABIA; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; HUMANS; MOLECULAR EPIDEMIOLOGY; PHENOTYPE; PREVALENCE; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SICKLE CELL TRAIT;

EID: 79959247655     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.81540     Document Type: Review

References (42)

1. Creary M, Williamson W, Kulkarni R. Sickle Cell Disease: Current activities, health implications, and future directions. J Womens Health (Larchmt) 2007;16:575-82. (Pubitemid 47093903)
2. Makani J, Williams TN, Marsh K. Sickle cell disease in Africa: Burden and research priorities. Ann Trop Med Parasitol 2007;101:3-14. (Pubitemid 47488079)
3. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: A 4-decade observational study of 1056 patients. Medicine (Baltimore) 2005;84:363-76. (Pubitemid 41668935)
4. Lehmann H, Maranjian G, Mourant AE. Distribution of sickle-cell hemoglobin in Saudi Arabia. Nature1963;198:492-3.
5. Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS, Al-Salloum AA, Al-Omar AA. The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi Med J 2008;29:1480-3.
6. AlHamdan NA, AlMazrou YY, AlSwaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 2007;9:372-7. (Pubitemid 46956479)
7. el-Hazmi MA, Warsy AS. Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia. East Mediterr Health J 1999;5:1147-53.
8. el-Hazmi MA. Clinical and haematological diversity of sickle cell disease in Saudi children. J Trop Pediatr 1992;38:106-12.
9. Gelpi AP. Migrant populations and the diffusion of the sickle cell gene. Ann Intern Med 1973;79:258-64.
10. Kulozik AE, Wainscoat JS, Serjeant GR, Kar BC, Al-Awamy B, Essan GJ, et al. Geographical survey of beta S-globin gene haplotypes: Evidence for an independent Asian origin of sickle-cell mutation. Am J Hum Genet 1986;39:239-44. (Pubitemid 16005416)
11. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364:1343-60. (Pubitemid 39335827)
12. Chui DH, Dover GJ. Sickle cell disease: No longer a single gene disorder. Curr Opin Pediatr 2001;13:22-7. (Pubitemid 32108783)
13. World Health Organization. Sickle-cell anaemia. Report by the Secretariat. Fifty-ninth World Health Assembly. Provisional agenda item 11.4. A59/9. WHO 2006. Available from: www.who.int/gb/ebwha/pdf-files/WHA59/A59-9-en. pdf [Last accessed on 2006].
14. McAuley CF, Webb C, Makani J, Macharia A, Uyoga S, Opi DH, et al. High mortality in children living with sickle cell anemia on the coast of Kenya. Blood 2010;116:1663-8.
15. Ministry of Economy and Planning, Kingdom of Saudi Arabia [Internet]. About Saudi Arabia Available from: http://www.mep.gov.sa/index.jsp;jsessionid= D427970121D611CD2C0C07846546A5C6.alfaevent=ArticleViewandArticle.ObjectID=15. [Last accessed on 2010 Jun 17].
16. El Mouzan MI, Al Salloum AA, Al Herbish AS, Qurachi MM, AL Omar AA. Consanguinity and major genetic disorders in Saudi children: A community-based cross-sectional study. Ann Saudi Med 2008;28:169-73.
17. Meyer BF. Strategies for the prevention of hereditary diseases in a highly consanguineous population. Ann Hum Biol 2005;32:174-9. (Pubitemid 40995619)
18. Nasserullah Z, Alshammari A, Abbas MA, Abu-Khamseen Y, Qadri M, Jafer SA, et al. Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency. Ann Saudi Med 2003;23:354-7. (Pubitemid 37527004)
19. Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and b-thalassemia in Saudi Arabia. Ann Saudi Med 2011;31:229-35.
20. Vichinsky EP. Comprehensive care in sickle cell disease: Its impact on morbidity and mortality. Semin Hematol 1991;28:220-6.
21. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11. (Pubitemid 28304491)
22. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crisis in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-22.
23. Grosse SD, Olney RS, Baily MA. The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: A critique. Appl Health Econ Health Policy 2005;4:239-47. (Pubitemid 43242212)
24. Panepinto JA, Magid D, Rewers MJ, Lane PA. Universal versus targeted screening of infants for sickle cell disease: A cost-effectiveness analysis. J Pediatr 2000;136:201-8. (Pubitemid 30470991)
25. Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. Screening for sickle cell disease and thalassaemia: A systematic review with supplementary research. Health Technol Assess 2000;4:1-99.
26. Al-Suliman A, Elsarraf A, Baqishi M, Homrany H, Bousbiah J, Farouk E. Patterns of mortality in adult sickle cell disease in Al-Hasa region of Saudi Arabia. Ann Saudi Med 2006;26:487-8. (Pubitemid 46195741)
27. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007;21:37-47. (Pubitemid 46110926)
28. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
29. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell diseae. N Engl J Med 2008;359:2254-65.
30. Padmos MA, Roberts GT, Sackey K, Kulozik A, Bail S, Morris JS, et al. Two different forms of homozygous sickle cell disease occur in Saudi Arabia. Br J Haematol 1991;79:93-8.
31. Serjeant GR. The geography of sickle cell disease: Opportunities for understanding diversity. Ann Saudi Med 1994;14:237-46. (Pubitemid 24227952)
32. Akinyoola AL, Adediran IA, Asaleye CM. Avascular necrosis of the femoral head in sickle cell disease in Nigeria: A retrospective study. Niger Postgrad Med J 2007;14:217-20.
33. Alabdulaali MK. Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes. Ann Thorac Med 2007;2:158-62.
34. Adekile A, Al-Kandari M, Haider M, Rajaa M, DSouza M, Sukumaran J. Hemoglobin F concentration as a function of age in Kuwaiti sickle cell disease patients. Med Princ Pract 2007;16:286-90. (Pubitemid 46854775)
35. Adekile AD, Yacoub F, Gupta R, Sinan T, Haider MZ, Habeeb Y, et al. Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high Hb F. Am J Hematol 2002;70:228-31. (Pubitemid 34680683)
36. Marouf R, Gupta R, Haider MZ, Adekile AD. Silents infarcts in adult Kuwaiti sickle cell disease patients. Am J Hematol 2003;73:240-3. (Pubitemid 36898880)
37. Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002;99:3014-8. (Pubitemid 34525393)
38. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-94. (Pubitemid 28018756)
39. Hawasawi ZM, Nabi G, Al Magamci MS, Awad KS. Sickle cell disease in childhood in Madina. Ann Saudi Med 1998;18:293-5. (Pubitemid 29319909)
40. El Sayed MM, Adeuja AO, El-Nahrawy E, Olaish MA. Characteristics of stroke in Hofuf, Saudi Arabia. Ann Saudi Med 1999;19:27-31. (Pubitemid 29319950)
41. Hellani A, Al-Akoum S, Abu-Amero KK. G6PD Mediterranean S188F codon mutation is common among Saudi sickle cell patients and increases the risk of stroke. Genet Test Mol Biomarkers 2009;13:449-52.
42. Weatherall D, Hofman K, Rodgers G, Ruffin J, Hrynkow S. A case for developing North-South partnerships for research in sickle cell disease. Blood 2005;105:921-3. (Pubitemid 40170855)